|
Thank you for your interest in UMBI technology. Please bear with us as we implement a searchable web interface. In the meantime here is a sampling of technology families available for licensing. If you would like additional information, or to discuss licensing/option terms please contact: Jonathan Gottlieb, Ph.D., MBA. Director, Technology Transfer and Commercialization, at (240) 314-6506 or gottlieb@umbi.umd.edu
Methods for generation, characterization and isolation of primary Human antibody responses in vitro
Targets for disruption and modification of polymerization events in neurodegenerative diseases
Fluorescent probes for real-time detection of Cyanide gas
Metal Enhanced Chemiluminescence
A novel marine bacteria for use in modifying DMS levels and as a biosynthetic fermenter
Zero discharge re-circulated marine aquaculture system and bio-filters to control ammonia levels
Anthrax Lethal Factor codon-optimized for delivery using a Salmonella Vaccine Vector
Novel Therapy for Herpes Virus Infections
Surface Layer Coated Biodegradable Micro Capsules for Oral Drug Delivery
Methods for production and strains for use as IBDV vaccines in Poultry (in-ovo) and marine environments (salmonid).
|
Jonathan Gottlieb, Ph.D., MBA
Director, Technology Transfer & Commercialization
UMBI Central Administration,Suite 200
701 East Pratt Street
Baltimore, MD 21202
Phone: (240) 314-6506
(410) 385-6331 (f)
gottlieb@umbi.umd.edu
|
|